ThyssenKrupp Don’t comply, don’t explain

ThyssenKrupp shareholders must vote against a proposed poison pill at this week’s annual general meeting. If they don’t, they will effectively forfeit the right to decide the future of the German steel-maker. Thyssen plans to give its major shareholder, the Alfred Krupp von Bohlen und Halback foundation, the right to nominate three members of the Supervisory Board, without requiring them to face a shareholder vote. The Foundation would then be able to ally with the 10 worker representative to b...